JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
1.0
Cite Score 2025
SJR: 0.129 / SNIP: 0.140
Volume 18, Issue 2 (2026)
Iran J War Public Health 2026, 18(2): 201-206 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2026/04/3 | Accepted: 2026/06/17 | Published: 2026/06/21
Received: 2026/04/3 | Accepted: 2026/06/17 | Published: 2026/06/21
How to cite this article
Jasim A, Ali B, Abdulbaqi M. CD35 Protein-Gene as a Diagnostic Biochemical of Iraqi Hepatic Cancer Patients. Iran J War Public Health 2026; 18 (2) :201-206
URL: http://ijwph.ir/article-1-1760-en.html
URL: http://ijwph.ir/article-1-1760-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Community Health Department, Polytechnic College-Karbala, Al-Furat Al-Awsat Technical University, Kufa, Iraq
2- Medical Laboratories Department, Polytechnic College-Karbala, Al-Furat Al-Awsat Technical University, Kufa, Iraq
2- Medical Laboratories Department, Polytechnic College-Karbala, Al-Furat Al-Awsat Technical University, Kufa, Iraq
Abstract (1017 Views)
Aims: CD35, a gene encoding a key protein involved in inflammation and immune regulation, has been implicated in the development of several cancers. This study aimed to investigate the relationship between CD35 tag single-nucleotide polymorphisms and susceptibility to hepatic carcinoma, as well as their potential association with postoperative recurrence, thereby contributing to a better understanding of gene–environment interactions in hepatic carcinoma.
Materials & Methods: This hospital-based observational study included 120 Iraqi participants, comprising 56 patients with hepatic carcinoma and 64 healthy controls. The study investigated whether CD35 tag single-nucleotide polymorphisms were associated with susceptibility to hepatic carcinoma and, among patients who underwent surgery, with postoperative recurrence. Three CD35 tag single-nucleotide polymorphisms—rs2296160, rs3849266, and rs7525160—were selected using HaploView version 4.2 and genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
Findings: Among 56 patients with hepatic carcinoma and 64 controls, CD35 rs2296160 and rs3849266 showed no significant genotype differences between groups (p>0.05). In contrast, rs7525160 was associated with hepatic carcinoma.The rs7525160 C-allele association was more evident in patients with tumors >5cm, TNM stage III/IV disease, cirrhosis, portal vein thrombosis, or AFP >400ng/mL. There was an association between the CC/CG genotype and postoperative recurrence; however, the hazard ratio and 95% confidence interval should be added.
Conclusion: Among Iraqi participants younger than 65 years, the CD35 rs7525160 polymorphism increases hepatic carcinoma susceptibility and predicts poorer recurrence-free survival.
Materials & Methods: This hospital-based observational study included 120 Iraqi participants, comprising 56 patients with hepatic carcinoma and 64 healthy controls. The study investigated whether CD35 tag single-nucleotide polymorphisms were associated with susceptibility to hepatic carcinoma and, among patients who underwent surgery, with postoperative recurrence. Three CD35 tag single-nucleotide polymorphisms—rs2296160, rs3849266, and rs7525160—were selected using HaploView version 4.2 and genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
Findings: Among 56 patients with hepatic carcinoma and 64 controls, CD35 rs2296160 and rs3849266 showed no significant genotype differences between groups (p>0.05). In contrast, rs7525160 was associated with hepatic carcinoma.The rs7525160 C-allele association was more evident in patients with tumors >5cm, TNM stage III/IV disease, cirrhosis, portal vein thrombosis, or AFP >400ng/mL. There was an association between the CC/CG genotype and postoperative recurrence; however, the hazard ratio and 95% confidence interval should be added.
Conclusion: Among Iraqi participants younger than 65 years, the CD35 rs7525160 polymorphism increases hepatic carcinoma susceptibility and predicts poorer recurrence-free survival.
Keywords: